 CANTEL MEDICAL CORP. NYSE:CMD Cantel or the Company today announced the sale of 28 million in aggregate principal amount of its 3.25 convertible senior notes due 2025 in respect of the Companys previously announced private offering of the notes to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended the Securities Act, pursuant to the full exercise by the initial purchasers of their option to purchase additional notes. The Company has issued a total of 168 million aggregate principal amount of the notes pursuant to such offering. 